Neurelis logo

Neurelis, Inc.


Neurelis Stock

Neurelis is a neuroscience-based pharmaceutical company focused on developing and commercializing life-changing therapies for people living with epilepsy and other neurological disorders. Its lead product, VALTOCO® (diazepam nasal spray), is a unique, FDA-approved treatment for acute seizure clusters.

Management Team

Craig Chambliss Co-Founder, CEO, and President
Jenny Alonzo General Counsel and Chief Compliance Officer
Brittany Bradrick COO and CFO
Chuck Dewildt Chief Commercial Officer
Stuart Madden, Ph.D. Chief Scientific Officer
Adrian Rabinowicz, M.D. Chief Medical Officer

Funding Information